SPTX on Nasdaq
Seaport Therapeutics, Inc.
American pharmaceutical preparations company based in Boston.
$17.57 up 0.89 (5.31%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 18, 2026.
Overview
Leadership
Who has led Seaport Therapeutics, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
- Chief financial officerLauren White Apr 30, 2026 to now4
Board members and other officers (13)
- Chief Medical OfficerAntony Loebel Apr 30, 2026 to now5
- Board memberDavid E. Wheadon Apr 30, 2026 to now6
- Board memberDenice Torres Apr 30, 2026 to now7
- Board memberJames Healy Apr 30, 2026 to now8
- Board memberJason Pitts Apr 30, 2026 to now9
- Board memberRobert J. Hombach Apr 30, 2026 to now10
- Board memberSandra E. Peterson Apr 30, 2026 to now11
- Board memberSharon Mates Apr 30, 2026 to now12
- Board memberAtlantic Genpar L.p. General May 6, 2026 to now13
- Board memberAtlantic (lux) S.a R.l. General May 6, 2026 to now14
- Board member(bermuda) L.p. Gap May 6, 2026 to now13
- Board memberCoinvestments Cda L.p. Gap May 6, 2026 to now14
- General counselLana Gladstein Apr 30, 2026 to now15
Filings
55 filings to the SEC since October 2021: 2 quarterly reports, 3 major events, 32 insider forms, 6 large holders, 1 private raises, 11 other. The latest 20:
- Aug 14, 2026SCHEDULE 13G EDGAR
- Aug 5, 2026SCHEDULE 13G EDGAR
- Aug 5, 2026SCHEDULE 13G EDGAR
- Aug 3, 202610-Q EDGAR
- Aug 3, 20268-K EDGAR
- Jun 24, 20264 EDGAR
- Jun 8, 202610-Q EDGAR
- Jun 8, 20268-K EDGAR
- May 11, 2026SCHEDULE 13D EDGAR
- May 11, 2026SCHEDULE 13G EDGAR
- May 6, 20264 EDGAR
- May 6, 2026SCHEDULE 13D EDGAR
- May 6, 20263 OWNERSHIP DOCUMENT EDGAR
- May 6, 20263 OWNERSHIP DOCUMENT EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
- May 4, 20264 EDGAR
The 55 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 6 such filings since October 2021:
- Aug 14, 2026SCHEDULE 13G
- Aug 5, 2026SCHEDULE 13G
- Aug 5, 2026SCHEDULE 13G
- May 11, 2026SCHEDULE 13D
- May 11, 2026SCHEDULE 13G
- May 6, 2026SCHEDULE 13D
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Oct 18, 2024Raised $225.9 million in a private offering of equity Form D: $226 million offered in all Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 54. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| ARCH Venture Management, LLC | 6,294,951 | $136.6M | 12.4% | New |
| General Atlantic, L.P. | 6,101,582 | $132.5M | 4.6% | New |
| Sofinnova Investments, Inc. | 3,564,871 | $77.4M | 4.1% | New |
| Goldman Sachs Group Inc | 2,178,642 | $47.3M | 0.0% | New |
| Trv Gp Vi, LLC | 2,061,222 | $44.8M | 19.3% | New |
| Canada Pension Plan Investment Board | 1,975,791 | $42.9M | 0.0% | New |
| Jpmorgan Chase & Co | 1,815,845 | $40.9M | 0.0% | New |
| Foresite Capital Management VI LLC | 1,779,521 | $38.7M | 6.0% | New |
| Fmr LLC | 1,185,100 | $25.7M | 0.0% | New |
| Bellevue Group AG | 1,100,000 | $23.9M | 0.5% | New |
| Siren, L.L.C. | 1,095,316 | $23.8M | 0.5% | New |
| Jennison Associates LLC | 1,079,669 | $23.5M | 0.0% | New |
| Ra Capital Management, L.P. | 700,000 | $15.2M | 0.1% | New |
| Vanguard Capital Management LLC | 599,217 | $13.0M | 0.0% | New |
| Woodline Partners LP | 586,345 | $12.7M | 0.0% | New |
| Perceptive Advisors LLC | 500,000 | $10.9M | 0.2% | New |
| Braidwell LP | 500,000 | $10.9M | 0.4% | New |
| Principal Financial Group Inc | 414,672 | $9.0M | 0.0% | New |
| Aberdeen Group plc | 310,355 | $6.7M | 0.0% | New |
| UBS Group AG | 279,184 | $6.1M | 0.0% | New |
| BlackRock, Inc. | 229,863 | $5.0M | 0.0% | New |
| Seven Grand Managers, LLC | 225,000 | $4.9M | 0.2% | New |
| Citadel Advisors LLC | 191,144 | $4.2M | 0.0% | New |
| Geode Capital Management, LLC | 175,866 | $3.8M | 0.0% | New |
| Pier Capital, LLC | 169,985 | $3.7M | 0.5% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceSPTX quote
- 3
- 4
- 5SEC EDGARAntony Loebel, Chief Medical Officer
- 6SEC EDGARDavid E. Wheadon, Board member
- 7SEC EDGARDenice Torres, Board member
- 8SEC EDGARJames Healy, Board member
- 9SEC EDGARJason Pitts, Board member
- 10SEC EDGARRobert J. Hombach, Board member
- 11SEC EDGARSandra E. Peterson, Board member
- 12SEC EDGARSharon Mates, Board member
- 13
- 14
- 15SEC EDGARLana Gladstein, General counsel